Syndax Pharmaceuticals Inc
SNDX
Revenue
12.50M
▲9.00M▲257.14%
3 Months ChangeAssets
724.82M
▲299.01M▲70.22%
3 Months ChangeLiabilities
436.69M
▲377.31M▲635.43%
3 Months ChangeFree Cash Flow
-20.04M
▼-20.04M-∞%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-01
Form 10-Q
ID: 0000950170-24-089241
2024-08-01
Form 8-K
ID: 0000950170-24-089235
2024-05-15
Form 8-K
ID: 0000950170-24-060462
2024-05-08
Form 10-Q
ID: 0000950170-24-055053
2024-05-08
Form 8-K
ID: 0000950170-24-055052
2024-03-18
Form 8-K
ID: 0000950170-24-032514
2024-02-27
Form 8-K
ID: 0000950170-24-021086
2023-12-20
Form 8-K
ID: 0000950170-23-071749
2023-12-15
Form 8-K
ID: 0001193125-23-296814
2023-12-12
Form 8-K
ID: 0000950170-23-069683